| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/30/1998 | CA2219377A1 Improvements in or relating to the prophylaxis of breast cancer |
| 04/29/1998 | EP0838523A2 RsbW-1 derived from Staphylococcus |
| 04/29/1998 | EP0838469A1 10,13,15-Trioxatricy-clo(9.2.1.1. 9.6)-pentadecanon derivatives, process for their preparation and medicament containing them |
| 04/29/1998 | EP0838464A1 Substituted benzo(b)thiophene compounds having activity as selective estrogen receptor modulators |
| 04/29/1998 | EP0838462A1 Benzothiophene compounds, intermediates, compositions, and methods |
| 04/29/1998 | EP0838461A2 Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity |
| 04/29/1998 | EP0838459A1 Naphthyl compounds, compositions, and methods |
| 04/29/1998 | EP0838453A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/29/1998 | EP0838221A1 Lyophilized hgf preparations |
| 04/29/1998 | EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque |
| 04/29/1998 | EP0837939A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 04/29/1998 | EP0837934A1 Human vascular endothelial growth factor 2 |
| 04/29/1998 | EP0837883A2 Method of solubilizing, purifying, and refolding protein |
| 04/29/1998 | EP0837863A1 Disodium alendronate formulations |
| 04/29/1998 | EP0837860A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO 3,4-c]-1,2,4-TRIAZOLO 4,3-$g(a)]PYRIDINES |
| 04/29/1998 | EP0837854A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 04/29/1998 | EP0837699A1 Immunovectors for the intracellular and intranuclear transport |
| 04/29/1998 | EP0837686A2 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 04/29/1998 | EP0801566A4 4,4-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 04/29/1998 | EP0465529B1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 04/29/1998 | CN1180358A Bridged indoles as matrix metalloprotease inhibitors |
| 04/29/1998 | CN1180357A 5H, 10H-imidazo £1, 2 -a| indeno £1, 2 -e| pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 04/29/1998 | CN1180352A Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 04/29/1998 | CN1180351A Benzothiazine dioxides as endothelin antagonists |
| 04/29/1998 | CN1180311A Use of 'alpha' 1L agonists in treatment of incontinence |
| 04/29/1998 | CN1180065A Antianaphylaxis, anti-asthma and anti-inflammatory new medicine |
| 04/29/1998 | CN1179980A Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 04/29/1998 | CN1179949A Drug-stopping addiction-removing capsule |
| 04/29/1998 | CN1179944A Use of strontium salts for production of pharmaceutical compositions intended for treatment of arthrosis |
| 04/29/1998 | CA2214866A1 Novel spo-rel |
| 04/28/1998 | US5744641 Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 04/28/1998 | US5744607 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 04/28/1998 | US5744586 Manufacturing process for the production of purified transferrin |
| 04/28/1998 | US5744499 Apoptosis-modulating factors influencing the intracellular concentration of methional/malondialdehyde |
| 04/28/1998 | US5744496 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| 04/28/1998 | US5744488 Indole derivatives thromboxane A2 antagonists |
| 04/28/1998 | US5744485 Carbamates and ureas as modifiers of multi-drug resistance |
| 04/28/1998 | US5744483 Neuroprotective compounds |
| 04/28/1998 | US5744477 Administering an inhibitor in combination with restricting the caloric intake of the subject |
| 04/28/1998 | US5744474 Administering venlafaxine or duloxetine; treating stress, urge and/or nocturnal urinary incontinence |
| 04/28/1998 | US5744471 Pyridazion quinoline compounds |
| 04/28/1998 | US5744466 Therapeutic heterocyclic compounds |
| 04/28/1998 | US5744464 Dysmennhorea |
| 04/28/1998 | US5744451 N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
| 04/28/1998 | US5744362 Antisense oligonucleotide modulation of raf gene expression |
| 04/28/1998 | US5744339 Thiomethylene group-containing aldehyde cysteine and serine protease inhibitors |
| 04/28/1998 | US5744338 DNA encoding seryl tRNA synthetase from Staphylococcus aureus |
| 04/28/1998 | US5744316 Used to identify individuals diagnosed with conditions characterized by cellular abnormalities |
| 04/28/1998 | US5744313 Assay employing novel protein domain which binds tyrosine phosphorylated proteins |
| 04/28/1998 | US5744157 Preparation for maintaining and/or increasing muscular power and body cell mass |
| 04/28/1998 | US5744125 Oxidative polymerization of precursors that enhance substantivity or adherence to hair or skin |
| 04/28/1998 | CA2077653C Phenyl butyl nitrone compositions for prevention of gastric ulceration |
| 04/28/1998 | CA1339843C Synergistic human interferon activity |
| 04/25/1998 | CA2218756A1 Substituted benzo¢b!thiophene compounds having activity as selective estrogen receptor modulators |
| 04/24/1998 | CA2215647A1 Naphthyl compounds, compositions, and methods |
| 04/23/1998 | WO1998016834A1 Diagnosis of spongiform encephalopathy |
| 04/23/1998 | WO1998016642A1 Keratinocyte growth factor-2 products |
| 04/23/1998 | WO1998016637A1 Fanconi gene 1 |
| 04/23/1998 | WO1998016551A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 04/23/1998 | WO1998016530A1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONE |
| 04/23/1998 | WO1998016523A2 Selective factor xa inhibitors |
| 04/23/1998 | WO1998016521A1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors |
| 04/23/1998 | WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016512A1 New derivates from piperidine-keto acid, their preparation and use |
| 04/23/1998 | WO1998016505A1 SULFONAMIDE INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 04/23/1998 | WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016502A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 04/23/1998 | WO1998016265A1 Liquid embolic agents containing partially hydrolyzed polyvinyl acetate |
| 04/23/1998 | WO1998016239A1 CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 04/23/1998 | WO1998016227A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 04/23/1998 | WO1998016226A1 Use of lofexidine in the treatment of behavioral disorders |
| 04/23/1998 | WO1998016222A1 Preparation of 3-fluoro oxindole derivatives |
| 04/23/1998 | WO1998016221A1 NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 04/23/1998 | WO1998016220A1 HESPERIDIN AND HESPERETIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 04/23/1998 | WO1998016213A1 Use of sodium 2-mercaptoethanesulfonate in surgery |
| 04/23/1998 | WO1998016203A1 Stabilized gas-supersaturated emulsions and suspensions |
| 04/23/1998 | WO1998016184A2 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998009992A3 Htm4, methods of treatment and assays, agonists and antagonists |
| 04/23/1998 | WO1998008548A3 Stable radioiodine conjugates and methods for their synthesis |
| 04/23/1998 | WO1998008546A3 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/23/1998 | WO1998004686A3 Pro-protein converting enzyme |
| 04/23/1998 | CA2268917A1 New derivates from piperidine-keto acid, their preparation and use |
| 04/23/1998 | CA2268904A1 Diagnosis of spongiform encephalopathy |
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268405A1 Stabilized gas-supersaturated emulsions and suspensions |
| 04/23/1998 | CA2268281A1 Selective factor xa inhibitors |
| 04/23/1998 | CA2268098A1 Aspartate ester inhibitors of interleukin-1.beta. converting enzyme |
| 04/23/1998 | CA2268086A1 Sulfonamide interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2267110A1 Fanconi gene i |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/22/1998 | EP0837137A2 Novel topoisomerase III |
| 04/22/1998 | EP0837133A2 DNA strand resolution proteins of the resolvase family |
| 04/22/1998 | EP0837129A1 Epimorphin antagonist and process for producing the same |
| 04/22/1998 | EP0837127A2 Hereditary multiple exostose gene, Ext2 |
| 04/22/1998 | EP0837073A1 Human mad proteins and uses thereof |
| 04/22/1998 | EP0837055A1 Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them |
| 04/22/1998 | EP0836853A1 Use of bradykinin antagonists for the manufacture of a medicament for treating Alzheimer's disease |
| 04/22/1998 | EP0836852A1 Use of amlexanox for the manufacture of a medicament for treating aphtous ulcers |
| 04/22/1998 | EP0836849A2 Pharmaceutical formulations containing gamma amino butyric acid, an anti-oxidant, folic acid, nicotinamide and a lithium salt |